Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

453 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An oncolytic virus as a promising candidate for the treatment of radioresistant oral squamous cell carcinoma.
Gohara S, Shinohara K, Yoshida R, Kariya R, Tazawa H, Hashimoto M, Inoue J, Kubo R, Nakashima H, Arita H, Kawaguchi S, Yamana K, Nagao Y, Iwamoto A, Sakata J, Matsuoka Y, Takeshita H, Hirayama M, Kawahara K, Nagata M, Hirosue A, Kuwahara Y, Fukumoto M, Okada S, Urata Y, Fujiwara T, Nakayama H. Gohara S, et al. Among authors: urata y. Mol Ther Oncolytics. 2022 Oct 8;27:141-156. doi: 10.1016/j.omto.2022.10.001. eCollection 2022 Dec 15. Mol Ther Oncolytics. 2022. PMID: 36381653 Free PMC article.
Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer.
Araki H, Tazawa H, Kanaya N, Kajiwara Y, Yamada M, Hashimoto M, Kikuchi S, Kuroda S, Yoshida R, Umeda Y, Urata Y, Kagawa S, Fujiwara T. Araki H, et al. Among authors: urata y. Mol Ther Oncolytics. 2022 Sep 13;27:3-13. doi: 10.1016/j.omto.2022.09.003. eCollection 2022 Dec 15. Mol Ther Oncolytics. 2022. PMID: 36212775 Free PMC article.
Immune Modulation by Telomerase-Specific Oncolytic Adenovirus Synergistically Enhances Antitumor Efficacy with Anti-PD1 Antibody.
Kanaya N, Kuroda S, Kakiuchi Y, Kumon K, Tsumura T, Hashimoto M, Morihiro T, Kubota T, Aoyama K, Kikuchi S, Nishizaki M, Kagawa S, Tazawa H, Mizuguchi H, Urata Y, Fujiwara T. Kanaya N, et al. Among authors: urata y. Mol Ther. 2020 Mar 4;28(3):794-804. doi: 10.1016/j.ymthe.2020.01.003. Epub 2020 Jan 10. Mol Ther. 2020. PMID: 31991110 Free PMC article.
Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer.
Koujima T, Tazawa H, Ieda T, Araki H, Fushimi T, Shoji R, Kuroda S, Kikuchi S, Yoshida R, Umeda Y, Teraishi F, Urata Y, Mizuguchi H, Fujiwara T. Koujima T, et al. Among authors: urata y. Mol Ther Oncolytics. 2020 Mar 31;17:107-117. doi: 10.1016/j.omto.2020.03.016. eCollection 2020 Jun 26. Mol Ther Oncolytics. 2020. PMID: 32322667 Free PMC article.
453 results